miR-21 also negatively regulates LPS-induced lipid accumulation and inflammatory responses in macrophages by modulating the TLR4–NF-κB pathway, indicating its potential application as a therapeutic agent for prevention and treatment of atherosclerosis (59). Here, NFKB1 is linked to atherosclerosis.